đź§ 

Ischemic Stroke Evaluation Guide

Nov 24, 2025

Overview

Case discussion of a 61-year-old hypertensive woman with acute right-sided weakness, facial deviation, and speech difficulty. Focus on stroke type differentiation, localization, exam findings, investigations, and management.

Patient Profile and Presentation

  • 61-year-old right-handed woman, Ramnagar; lower-middle socioeconomic status; educated to 8th standard.
  • Risk factors: Hypertension (8 years, on amlodipine); postmenopausal age; no diabetes, cardiac disease, smoking, or alcohol.
  • Chief complaints (5 days): sudden right upper and lower limb weakness, left mouth angle deviation, slurred speech.
  • Functional impact: difficulty holding glass, combing hair (distal > proximal suggested), squatting, gripping slippers.
  • No: headache, vomiting, LOC, seizures, visual loss, sensory symptoms, imbalance, dysphagia, chest pain, palpitations.

Stroke Typing by History

  • Timing: woke with deficits (early morning onset favors thrombotic ischemic stroke).
  • Deficit at onset: not maximal; progressed over hours (stepwise progression favors thrombosis).
  • Progression mechanism: expanding infarct core; ischemic penumbra injury via reduced flow and excitotoxic edema.

Coagulation and Circadian Concept

  • Fibrinolysis control: tissue plasminogen activator activates plasminogen; countered by plasminogen activator inhibitor (PAI).
  • Early morning: higher PAI levels reduce fibrinolysis, favoring thrombosis; age-related endothelial injury adds risk.

Focal Deficits and Localization

  • Motor: right hemiparesis; UMN pattern (distal weakness appears early in UMN lesions).
  • Face: UMN-type right facial weakness (forehead spared), deviation to left; suggests supranuclear lesion.
  • Speech: differentiate dysarthria (articulation, facial/tongue/velar muscles) vs aphasia (language, cortical).
    • Facial involvement supports dysarthria (labial sounds affected).
    • True Broca’s aphasia implies dominant frontal cortex; dense internal capsule lesion alone does not cause aphasia.
  • Sensory: no deficits reported; favors internal capsule motor pathways if pure motor.

Ecology of Stroke: Key Differentiators

  • Thrombotic: early morning, progressive, not maximal at onset; recurrent similar TIAs (low-flow), lacunar patterns.
  • Embolic: maximal at onset; spontaneous improvement within 24–48 h as embolus lyses; TIAs varied (“shotgun”).
  • Hemorrhagic: often during activity; headache, vomiting, altered sensorium; worsening from edema, mass effect.

TIAs: Anterior vs Posterior

  • Anterior (carotid): amaurosis fugax (ophthalmic artery), transient mono-weakness, sensory loss, aphasia.
  • Posterior (vertebrobasilar): vertigo, ataxia, dysarthria, dysphagia, ophthalmoplegia, hiccups.
  • TIA prognosis: high short-term stroke risk; many within 1 week, most within 3 months.

Hypertension and Stroke Patterns

  • Ischemic more common overall; lacunar infarcts typical in HTN.
  • Lacunar syndromes: pure motor, pure sensory, ataxic hemiparesis, dysarthria–clumsy hand, mixed.
  • Lacunar sites: posterior limb internal capsule (common), corona radiata, basis pontis, thalamus, genu; cerebellum (rare).
  • Hypertensive hemorrhage sites: putamen (commonest), pons, cerebellum; lobar hemorrhage uncommon.

Examination Highlights

  • Vitals: normal pulse; BP 128/90; afebrile; JVP normal.
  • General: BMI 22.7 (nutritional status should align with normal).
  • Higher mental functions: oriented; memory intact; reduced fluency; repetition affected; reading/writing not possible; comprehension normal.
  • Cranial nerves:
    • II: acuity and fields normal; fundus needed (papilledema, hypertensive changes, subhyaloid hemorrhage).
    • III, IV, VI: full movements; pupils reactive.
    • V: normal; jaw jerk absent (unilateral UMN does not augment jaw jerk).
    • VII: right UMN facial palsy; preserved eye closure, loss of right nasolabial fold; mouth deviates left.
    • IX, X, XII: clinically no dysphagia; articulation may be affected by VII.
  • Motor: increased tone (spasticity); right power 3/5; left 5/5.
    • Spasticity features: velocity-dependent; anti-gravity pattern; clasp-knife phenomenon.
  • Reflexes: right DTRs exaggerated; right abdominal reflex absent; right plantar extensor; left normal.
  • Sensory: intact.
  • Cerebellar: not testable on weak side; normal on left.
  • Vascular auscultation: no carotid or skull bruits; should assess carotid and vertebral bruits along defined surface anatomy.
  • CVS/RS/Abdomen: normal; ensure full documentation (apex, cardiomegaly absent, S3/S4, murmurs).

Bedside Vascular Examination Essentials

  • Carotid bruit: along carotid in anterior triangle (palpate then auscultate).
  • Vertebral artery: line from medial clavicle (first part subclavian) to mastoid; auscultate along this path.
  • Absence of bruit does not exclude severe occlusion (complete occlusion may be silent).

Investigations

  • Neuroimaging: non-contrast CT first (exclude hemorrhage); MRI DWI/T2 for infarct; CT/MR angiography for vessel status.
  • Cardiac: ECG, echocardiography (cardioembolism, structural disease).
  • Vascular: carotid and vertebral Doppler.
  • Labs: CBC (Hb, platelets), glucose and HbA1c, lipid profile; coagulation tests mainly if hemorrhage suspected; uric acid as needed.

Management

  • Thrombolysis window: within 4.5 hours (alteplase 0.9 mg/kg; 10% bolus, 90% over 60 min).
  • Thrombolysis considerations:
    • BP must be ≤185/110 mmHg prior; reduce if needed.
    • Absolute contraindications include thrombocytopenia (<100K), marked hypo/hyperglycemia (<50 or >400), recent heparin (48 h), recent stroke (3 months), recent major surgery (14 days), recent GI bleed (21 days).
  • Antithrombotic therapy: dual antiplatelet (aspirin + clopidogrel) in early phase; statin irrespective of baseline lipids (pleiotropic vascular benefits).
  • BP management:
    • Ischemic (no thrombolysis): avoid rapid lowering initially; maintain perfusion; gradual reduction over 24 h.
    • Hemorrhagic: reduce BP promptly (first 6–12 h) to limit expansion.
  • Supportive care: glucose control; DVT prophylaxis; swallow assessment/feeding; bladder care; pneumonia/UTI prevention; early rehab.
  • Rehabilitation: start day 1 if no thrombolysis and hemodynamically stable; after thrombolysis, begin after 24 hours if stable.

Aphasia vs Dysarthria: Clinical Differentiation

  • Aphasia: language disorder (comprehension, naming, repetition, reading/writing); cortical localization (dominant hemisphere).
    • Broca’s aphasia: non-fluent, impaired repetition, good comprehension, minimal word output.
  • Dysarthria: motor articulation (labials: p/b; linguals: t/d/n; velars: k/g); cranial nerves VII, IX/X, XII; can accompany internal capsule lesions.

Stroke Mimics

  • Organic: brain tumors, subdural/epidural hematomas, infections (meningitis with vasculitis), metabolic (hypo/hyperglycemia), post-ictal Todd’s paresis.
  • Venous: cerebral venous thrombosis (often with fever).
  • Functional: non-organic presentations.

Examination and History Tips

  • Always document deficit evolution, hospital delay reasons, and status change after admission.
  • Ask for complications: DVT (limb pain/swelling), pneumonia, UTI, bedsores, fever.
  • TIA characterization: anterior vs posterior features; pattern similarity (thrombotic) vs variability (embolic).
  • Family history: young strokes—prothrombotic disorders (protein C/S deficiency, factor V Leiden), sickle cell, CADASIL, aneurysms, moyamoya.
  • Personal history: diet (B12 deficiency; hyperhomocysteinemia), drug use (cocaine), sexual history (HIV/syphilis), OCP only in premenopausal.

Provisional Diagnosis and Localization

  • Likely ischemic thrombotic stroke in left MCA territory.
  • Pure motor signs with UMN facial palsy favor left internal capsule (posterior limb) if no aphasia.
  • If convincing Broca’s aphasia present, lesion localizes to dominant frontal cortex; MCA superior division involvement; dense capsular signs would suggest larger MCA stem involvement.

Key Terms & Definitions

  • Ischemic core: irreversibly infarcted tissue.
  • Ischemic penumbra: hypoperfused, salvageable tissue around core.
  • PAI: plasminogen activator inhibitor; suppresses tPA-mediated fibrinolysis.
  • Dysarthria–clumsy hand: lacunar syndrome with articulation deficit and fine motor clumsiness.
  • Amaurosis fugax: transient monocular vision loss due to ophthalmic artery ischemia.
  • Cushing’s reflex: bradycardia and hypertension with raised intracranial pressure.
  • Todd’s paralysis: transient post-ictal focal weakness.

Structured Comparisons

FeatureThrombotic IschemicEmbolic IschemicHemorrhagic
Onset timingOften on waking (early morning)Any time, often during activityOften during activity
Deficit at onsetNot maximal; stepwise progressionMaximal at onsetWorsens with edema/mass effect
ProgressionHours to day; new signs may addPossible improvement 24–48 hEarly worsening, later improve
Headache/vomitingUncommonVariableCommon; projectile vomiting, headache
TIA patternRecurrent similar deficitsFrequent, variable deficitsNot applicable
Imaging (first test)Non-contrast CT to exclude bleedSameNon-contrast CT shows bleed
SyndromeKey SignsLikely Site
Pure motor strokeContralateral hemiparesis, no sensoryInternal capsule (posterior limb)
Pure sensory strokeContralateral hemisensory lossThalamus
Ataxic hemiparesisIpsilateral ataxia with weaknessBasis pontis/corona radiata
Dysarthria–clumsy handDysarthria, clumsy fine movementsInternal capsule/genu
Lateral medullary (Wallenberg)Vertigo, dysphagia, hiccups, sensory dissociationPICA/lateral medulla

Action Items / Next Steps

  • Ensure fundus examination documentation (papilledema, hypertensive retinopathy, subhyaloid hemorrhage).
  • Clarify speech disorder as aphasia vs dysarthria using repetition, naming, reading/writing, and articulation tests.
  • Document carotid and vertebral bruits with correct surface anatomy.
  • Complete systemic exam write-ups (CVS apex/cardiomegaly, RS, abdomen).
  • Confirm imaging: MRI DWI and vascular study to localize lesion (internal capsule vs cortical MCA).
  • Optimize secondary prevention: dual antiplatelet (initial phase), statin, BP and glucose targets, risk factor modification.
  • Initiate/continue early multidisciplinary rehabilitation; monitor for complications (DVT, pneumonia, UTI).